Uncategorized
How one special Pink Day helps save and support cancer patients
When Rachel Wojnilower was an undergraduate at American University in Washington, D.C., she did all kinds of activities with her Jewish sorority, Alpha Epsilon Phi. Now 36, Wojnilower has let most of them fade from memory.
But in retrospect, one in particular stands out.
That’s because about five years after graduating, Wojnilower got married and underwent genetic testing along with her husband as they both prepared for future children. They were surprised when they each tested positive as carriers of a potentially dangerous mutation, and even more so when Wojnilower learned, after additional testing, that she also carried a mutation in the BRCA1 gene.
Such mutations, which are 10 times more common among Ashkenazi Jewish men and women than among the general U.S. population, significantly elevate the risks for breast cancer and ovarian cancer, and also increase the risks for melanoma, pancreatic and prostate cancers.
Without any intervention, there was a 50-50 chance that the couple would pass down this dangerous mutation to their children. Wojnilower didn’t know what to do.
“As you can imagine, my stress and anxiety levels were through the roof,” Wojnilower recalled. “I didn’t know a single person who had ever gone through this before.”
Then she remembered one of the volunteer opportunities she had done with Alpha Epsilon Phi: a fundraising drive for Sharsheret, the national Jewish breast cancer and ovarian cancer organization.
Wojnilower reached out to Sharsheret and spoke to one of organization’s social workers, who explained more about the mutation and what measures she could take to protect her health and that of her future children. The social worker connected Wojnilower with a trained peer supporter — another young woman who had had a very similar experience.
Ultimately, Wojnilower and her husband decided to pursue pre-implantation genetic diagnosis (PGD) — a cutting-edge procedure used with in-vitro fertilization (IVF) to screen embryos. This enabled them to identify which embryos were lower-risk and thereby reduce the chances of passing on the BRCA mutation.
Wojnilower has since given birth to two healthy children, both free of the genetic mutations that she and her husband carry.
“That’s really the essence of what we do at Sharsheret, which is Hebrew for the word chain. We are connecting women, families, and communities to each other and to life-changing and, quite frankly, lifesaving resources,” said Jordana Altman, Sharsheret’s director of marketing and communications. “Whatever the issue may be, you’re not alone, and we have skilled trained professionals and a community of thousands who together form a chain of support and information.”
Sharsheret Pink Day events, like this student-run fundraiser at Binghamton University, now take place at more than 150 college campuses, Jewish day schools and companies around the world. (Courtesy of Phi Mu Chapter of Alpha Epsilon Phi at Binghamton University)
In the years since Wojnilower was a student, Sharsheret has expanded its activities on college campuses and in Jewish day schools much more widely. One centerpiece of Sharsheret’s activities on campus is Sharsheret Pink Day — an annual day in February dedicated to the cause during which students and faculty dress in pink and undertake other activities to raise awareness of the risks for breast cancer and ovarian cancer as well as Sharsheret’s critical support programs.
The goal of Pink Day is to engage young people to participate in activities that they will remember later in life so that when one of them confronts a cancer-related challenge or helps someone who is, they’ll remember the resources Sharsheret offers. This year, Sharsheret hosted Pink Day activities around the United States at college campuses, Jewish high schools and day schools.
“We are planting seeds about Sharsheret,” said Ellen Kleinhaus, Sharsheret’s regional director of education and outreach. “While today you may only need Sharsheret to better understand your risk, you or someone you love will need Sharsheret for support in the future. There isn’t a family or a community out there that is not touched by breast cancer or ovarian cancer.”
Pink Day’s origins can be traced to 2006, when a New Jersey Jewish high school organized a dedicated day for students to support Sharsheret by wearing pink and sharing resources with their parents.
“It was such a memorable part of my high school experience,” said Tzvi Solomon, one of the students who initiated Sharsheret Pink Day. “People really rallied around it.”
Solomon was so inspired by the event that when he went to Israel for his gap year, he asked peers in the United States and Israel to bring Pink Day to their schools. Now an international initiative, the program engages thousands of participants at more than 150 schools and companies globally.
“I think it’s a reflection of our community being sensitive and recognizing the importance of having an organization like Sharsheret,” said Solomon, whose young son wore a pink shirt to school on this year’s Sharsheret Pink Day.
Amanda Goldsmith, 28, has been involved with Sharsheret since her Jewish day school hosted a Pink Day. Years later, while attending New York University, Goldsmith remembered Sharsheret when her parents called her one morning to inform her that her mother had just been diagnosed with breast cancer. Goldsmith immediately turned to Sharsheret for help and information, and she referred her mother to the organization’s peer support network.
During her mother’s treatment, Goldsmith vowed that once her mother was cancer free she’d start an initiative to get college students in New York City more involved with Sharsheret. She ended up establishing a local student board for the organization in New York City.
On Sharsheret Pink Day last year, Goldsmith, a human resource professional, implemented Wear Pink at Work, where her colleagues gave a $5 donation to Sharsheret and wore pink to the office. Her family also established a new Sharsheret program for young adults called YAD: The Young Adult Corner, which helps young adults understand their loved ones’ diagnoses, provides peer support and manages a website about cancer for young adults.
“It’s really just about spreading Sharsheret’s mission because they do so much good for so many people,” said Goldsmith, whose mother is now cancer free. “Pink Day might seem like something relatively small, but it’s hugely important.”
To learn more about Sharsheret, YAD: Young ADult Caring Corner or Sharsheret Pink Day 2024, email info@sharsheret.org.
—
The post How one special Pink Day helps save and support cancer patients appeared first on Jewish Telegraphic Agency.
Uncategorized
Teen slashed in Brooklyn synagogue by fellow congregant
(JTA) — A 14-year-old boy was slashed on Monday evening inside a Brooklyn synagogue by a suspect the police called an “emotionally disturbed person.”
The 22-year-old suspect, Krybus Shimon, is a fellow congregant of Yeshiva Gevoah Toldos, an Orthodox synagogue in Borough Park, the New York Police Department said. He was taken into custody and charged on Monday with assault, reckless endangerment and criminal possession of a weapon.
The boy’s hand was slashed with a “cutting instrument” and he was treated by emergency medical services on the scene, police said.
The incident is not currently being investigated as a hate crime, and it’s not yet clear what led to the slashing.
Borough Park is one of the largest Orthodox enclaves in the United States, home to about 96,000 Jews, according to UJA-Federation of New York.
In January, the neighborhood was hit with a spate of antisemitic vandalism. Over 70 swastikas and the words “Adolf Hitler” were sprayed over two days across Gravesend Park, a playground in Borough Park. Two 15-year-old boys were arrested for the vandalism and charged with aggravated harassment and criminal mischief as a hate crime.
New York Gov. Kathy Hochul last week announced a record $70 million in security funding for houses of worship, schools, community centers and other nonprofit organizations that are vulnerable to hate crimes and attacks because of their ideology, beliefs or mission.
This article originally appeared on JTA.org.
The post Teen slashed in Brooklyn synagogue by fellow congregant appeared first on The Forward.
Uncategorized
Staunch Israel supporter Coons expected to win Delaware Democratic Senate primary handily
(JTA) — Delaware incumbent Sen. Chris Coons, a longtime supporter of Israel, is expected to easily win Delaware’s U.S. Senate primary on Tuesday, despite criticism from party progressives.
Coons, a mainstay of the Senate Foreign Relations Committee, has repeatedly backed measures to bolster Israel’s capacity for self-defense. He also joined a bipartisan delegation to visit Israel immediately after the October 7, 2023, Hamas attacks.
But the senator has faced pushback in recent months for his refusal to back measures that would cut military aid to Israel.
This past spring, he was one of just seven Democrats to join Republicans in voting against a resolution authored by independent Vermont Sen. Bernie Sanders, which sought to stop the sale of military bulldozers to Israel. Coons was among just 11 Democrats who opposed a second Sanders resolution that proposed similar sales bans on massive bombs and other defense equipment.
Coons has served nearly three terms in the Senate. He won a special election in 2010, about a year after Joe Biden resigned to become U.S. vice president, and then went on to secure two full terms in 2014 and 2020.
In Tuesday’s primary, he will face off against artificial intelligence systems builder and historian Jeff Appelhans, naval architect and marine engineer Mary Louve and a former business executive who changed his legal name from Eric Hansen to E. No-Trump Hansen.
While Coons has earned endorsements from establishment Democrats, such as Delaware Sen. Lisa Blunt Rochester and Gov. Matt Meyer, he has drawn criticism from party progressives for both his support of Israel and the financial backing he gets from the American Israel Public Affairs Committee, the pro-Israel lobbying group.
Of Coons’s opponents, the most vocal critic on Israel-related policy has been Appelhans, whose campaign priorities included ending U.S. support for Israel’s war in Gaza. Appelhans slammed Coons for voting against the Sanders bills, writing on his campaign site that “the liberal consensus moved to block the sales.”
Appelhans condemned Coons’s voting record on “moving armaments to Israel,” noting in a recent interview that “there’s never been a vote that he’s stopped” on this issue. He was speaking with Delaware Public Media last week as part of a series of candidate interviews.
Regarding the conflict in Iran, Appelhans slammed “Congress’ unwillingness” to challenge the president, noting that “there was very much a sense that Israel would be a staunch ally and they could sort of get this done really easily.”
In the same radio series, another candidate, Louve, expressed uncertainty as to “why we’re still backing Israel,” while acknowledging the country’s history as a U.S. ally.
“Is it worth us continuing to step up for a bully?” she asked. “It’s aggression that is unnecessary that’s continuing to escalate because we’re helping it.”
Hansen did not participate in these conversations, Delaware Public Media stated.
This summer Coons pledged to stop taking donations from the data company Palantir, which has come under scrutiny for its work with the Israel’s Defense Ministry, the U.S. military and U.S. Immigration and Customs Enforcement, according to the nonprofit news site Spotlight Delaware.
Despite his more centrist reputation, Coons has had significant criticism for the Trump administration’s strategies in Iran. In his own Delaware Public Media interview, Coons accused the president of selling the conflict “as a cheap, quick war.”
While little polling data was available ahead of Tuesday’s race, the Polymarket predictions site gave Coons a 99.7% chance of winning as of Monday evening. In his last primary in 2020, Coons defeated a progressive opponent, Jessica Scarane, with nearly 73% of voter support.
Regardless of Tuesday’s outcome, the victor is expected to easily defeat the Republican challenger in the November general election, with the Cook Political Report deeming Delaware “solid” Democratic territory.
This article originally appeared on JTA.org.
The post Staunch Israel supporter Coons expected to win Delaware Democratic Senate primary handily appeared first on The Forward.
Uncategorized
Noah Wyle wins an Emmy for playing one of TV’s most Jewish doctors
(JTA) — Noah Wyle on Monday night won his second consecutive Emmy for playing Dr. Michael “Robby” Robinavitch on “The Pitt.” The win also marked a second victory for one of television’s more fully realized Jewish characters.
The actor won Outstanding Lead Actor in a Drama Series for the HBO Max medical drama, which also won Outstanding Drama Series for the second year in a row. In his acceptance speech, Wyle recalled growing up in Los Angeles and said, “This is all I’ve ever wanted to do, and this is the only club I’ve ever wanted to join.”
For Jewish viewers, the significance of Wyle’s victory goes beyond the actor’s own Jewish ancestry. In the first season, Robby was seen reciting the Shema at one of his lowest moments, turning what might have been a throwaway piece of character background into an intimate expression of fear and faith.
In the second season, Wyle, who is also a writer and executive producer on the show, pushed that dimension further. An episode he wrote dealt with the trauma of the 2018 Tree of Life synagogue shooting in Pittsburgh, while also exploring Robby’s complicated relationship with his Jewish faith.
Wyle has described Robby’s faith as something he is still “grappling” with — including the question of whether he has faith at all. The Shema scene, he said, functioned almost like a child’s primal plea for help.
Wyle was not the only Jewish winner of the night. Saul Metzstein, the Scottish Jewish director whose father was the prominent modernist architect Isi Metzstein, won Outstanding Directing for a Drama Series for “Slow Horses.” Metzstein had been competing against Wyle, who was nominated for directing an episode of “The Pitt.”
Those two wins were among the relatively few Jewish victories at this year’s ceremony. Jewish actors including Jason Segel, Lisa Kudrow, Harrison Ford and Hannah Einbinder were among the nominees but did not win in their categories.
“Nobody Wants This,” the Netflix show about a rabbi’s romance with a non-Jewish podcaster, was nominated for Outstanding Comedy Series but lost to “Widow’s Bay.”
An Emmy was also awarded to a Jewish actor and director whose death in 2025 stunned the industry and a legion of fans. Rob Reiner, who was killed in December with his wife, Michele, won a posthumous Emmy for his guest role as a kind dispenser of business advice on “The Bear.” Reiner’s award was presented at the Creative Arts Emmys earlier this month, rather than Monday’s televised ceremony.
Reiner, before going on to direct Hollywood classics like “This Is Spinal Tap,” “The Princess Bride” and “When Harry Met Sally” won his first two Emmy awards in 1974 and 1978 for playing Mike Stivic, the liberal son-in-law of Archie Bunker on “All in the Family.”
This article originally appeared on JTA.org.
The post Noah Wyle wins an Emmy for playing one of TV’s most Jewish doctors appeared first on The Forward.
